Home › Sikkelcelziekte › New York › New York City
Sikkelcelziekte klinische studies in New York City, NY
13 studies voor Sikkelcelziekte zoeken deelnemers op locaties in en rond New York City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
RekruterenFase 1
- Mount Sinai Hospital, New York
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
RekruterenFase 3
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
RekruterenFase 2/3
- Icahn School of Medicine at Mount Sinai, New York
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RekruterenObservatieonderzoek
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
RekruterenFase 2
- Mount Sinai Medical Center, New York
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
RekruterenFase 1/2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
RekruterenFase 1
- Columbia University Irving Medical Center, New York
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
RekruterenObservatieonderzoek
- Columbia Presbytarian (NT-DMT), New York
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RekruterenFase 3
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
RekruterenFase 2
- Columbia University, New York
A Long-term Follow-up Study in Patients Who Received BEAM-101
RekruterenObservatieonderzoek
- Columbia University Irving Medical Center, New York
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Rekruteren
- Weil Cornell Medical College, New York
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
RekruterenFase 2
- Mount Sinai Hospital, New York
Sikkelcelziekte studies in andere steden
- Atlanta, GA22 studies
- Washington, DC20 studies
- Chicago, IL18 studies
- Memphis, TN18 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- St. Louis, MO12 studies
- Boston, MA10 studies
- Durham, NC10 studies
- Houston, TX10 studies
- Cincinnati, OH10 studies
- Greenville, NC9 studies
Andere studies in New York City
- Borstkanker136 studies
- Niet-kleincellige longkanker121 studies
- Kanker (alle vormen)109 studies
- Prostaatkanker103 studies
- Metastatische kanker93 studies
- Colorectale kanker78 studies
- Eierstokkanker69 studies
- Longkanker60 studies
- Multipel myeloom60 studies
- Aldermeesklierkanker60 studies
- Endometriumkanker52 studies
- Acute myeloïde leukemie51 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.